Titlebook: Cystogenesis; Jong Hoon Park,Curie Ahn Book 2016 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Natu

出租

書目名稱Cystogenesis影響因子(影響力)




書目名稱Cystogenesis影響因子(影響力)學(xué)科排名




書目名稱Cystogenesis網(wǎng)絡(luò)公開(kāi)度




書目名稱Cystogenesis網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書目名稱Cystogenesis被引頻次




書目名稱Cystogenesis被引頻次學(xué)科排名




書目名稱Cystogenesis年度引用




書目名稱Cystogenesis年度引用學(xué)科排名




書目名稱Cystogenesis讀者反饋




書目名稱Cystogenesis讀者反饋學(xué)科排名

collateral

Friction

Cell Proliferation and Apoptosis in ADPKDisruption of either . or ., the main causative genes of ADPKD, intracellular calcium homeostasis and cAMP accumulation are disrupted, which in turn leads to altered signaling in the pathways that regulate cell proliferation. These dysregulations finally stimulate the development of fluid-filled cyst

乞討

Inflammation and Fibrosis in ADPKDtant pathway related to this disease. However, studies on the interactions of inflammation and fibrosis with polycystic kidney disease have been limited. Inflammation is one of the protective systems involved in the response to foreign molecules. In PKD, it was reported that the activity of signalin

籠子

Functional Study of the Primary Cilia in ADPKDays such as Wnt, PDGFRα, Hh, and mechanosignaling are localized to the membrane of the primary cilium. In the kidney, primary cilia extend from the cell membrane to the lumen of renal tubules to respond to fluidic stress. Recent studies have indicated that the disruption of ciliary proteins includin

dowagers-hump

Epigenetic Regulation in Cystogenesismodification, and gene regulation by microRNAs are well-known epigenetic modulations that are closely associated with several cellular processes and diverse disease states, such as cancers, even under precancerous conditions. More recently, several studies have indicated that epigenetic changes may

dowagers-hump

occult

Diagnostic Evaluation as a Biomarker in Patients with ADPKD declines over a long period of time, the evaluation of treatment effects in ADPKD has been very difficult. Therefore, there has been a great interest to find out the “better” surrogate marker or biomarker which reflects disease progression. Biomarkers in ADPKD should have three clinical implication

Mercurial

Clinical Trials and a View Toward the Future of ADPKDies, autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary disease, and is characterized by the progressive enlargement of bilateral renal cysts, resulting in end-stage kidney failure. Progress in genetics and molecular pathobiology has enabled the development of therape

擁護(hù)